Aktien Sensor

Pfizer’s stock price may not be a value play, but rather a cautionary tale of a company struggling to stay ahead of the curve due to lack of innovation, competition, and regulatory risks.

Eli Lilly & Co.’s stock price has stabilized, driven by positive results from a study on its Alzheimer’s treatment, Kisunla, which has generated enthusiasm among investors.

Cencora Inc. has partnered with LOCK’DIN to distribute its functional hydration products, marking a bold step into the hydration market and a shift towards a more holistic approach to health and wellness.

Bristol-Myers Squibb’s reputation as a safe dividend stock may be shaken by its decision to invest in biotechnology and immunology treatments, which comes with significant risks and challenges.

CVS Health Corp’s stock is poised for growth, driven by its focus on telehealth and telemedicine, with analysts predicting a bright future for the company.

Universal Health Services Inc reported strong second-quarter financial results, exceeding Wall Street estimates for profit and revenue.

Stryker Corp has launched the InThrill Thrombectomy System, a medical technology designed to improve thrombectomy procedures and address small vessel thrombus cases.

Sysmex Corp, a Japanese healthcare equipment company, is well-positioned to benefit from the growing demand for molecular diagnostics, despite a recent decline in its stock price.

Becton Dickinson & Co. has secured FDA clearance for its BD Veritor System for SARS-CoV-2, a digital COVID-19 test that delivers rapid results in 15 minutes.

Fosun Pharmaceutical’s stock price has surged by nearly 25% over the past 10 trading days, driven by growing investor interest in the company’s innovative products and strong fundamentals.